Management of migraine headache in the emergency department

Seminars in Neurology

Volumn 30, Issue 2, 2010, Pages 201-212

  Robertson, Carrie E ^a   Black, David F ^a   Swanson, Jerry W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dihydroergotamine; Headache; Migraine; Status migrainosus; Triptan

Indexed keywords

ALMOTRIPTAN; BENZATROPINE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; DIHYDROERGOTAMINE MESILATE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; ELETRIPTAN; ERGOTAMINE; FROVATRIPTAN; HALOPERIDOL; KETOROLAC; MAGNESIUM SULFATE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PETHIDINE; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; RIZATRIPTAN; SEROTONIN AGONIST; STEROID; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID; ZOLMITRIPTAN;

ABDOMINAL CRAMP; AKATHISIA; ANXIETY DISORDER; CHEST PRESSURE; CHEST TIGHTNESS; CLINICAL TRIAL; CLUSTER HEADACHE; DIARRHEA; DIZZINESS; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG FATALITY; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DYSTONIA; EMERGENCY CARE; EMERGENCY WARD; EXTRAPYRAMIDAL SYMPTOM; FLUID RETENTION; FLUID THERAPY; FLUSHING; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOTENSION; LEG PAIN; LIMB HEAVINESS; LIMB WEAKNESS; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; OPIATE ADDICTION; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PARKINSONISM; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SEIZURE; SIDE EFFECT; SKIN TINGLING; SOMNOLENCE; THORAX PAIN; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION; VOMITING;

ANALGESIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CALCITONIN GENE-RELATED PEPTIDE; DOPAMINE ANTAGONISTS; EMERGENCY MEDICAL SERVICES; ERGOTAMINE; FEMALE; HUMANS; MAGNESIUM SULFATE; MIGRAINE DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TRYPTAMINES;

EID: 77950523883     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0030-1249228     Document Type: Review

References (71)

1. Pitts S R., Niska R W., Xu J, Burt C W. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report 2008 (7) 1-38
2. Goldstein J N., Camargo C A. Jr, Pelletier A J., Edlow J A. Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses. Cephalalgia 2006 26 (6) 684-690
3. Friedman B W., Hochberg M L., Esses D et al. Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann Emerg Med 2007 49 (4) 409-419 e1-e9
4. Silberstein S D., Freitag F G., Bigal M E. Migraine treatment In: Silberstein SD, Lipton RB, Dodick DW Wolff's Headache. 8th ed. Oxford Oxford University Press 2008
5. Vinson D R., Drotts D L. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med 2001 37 (2) 125-131
6. Lake C R., Casey D E., McEvoy J P., Siris S G., Boyer W F., Simpson G. Anticholinergic prophylaxis in young adults treated with neuroleptic drugs. Psychopharmacol Bull 1986 22 (3) 981-984
7. Silberstein S D., Young W B., Mendizabal J E., Rothrock J F., Alam A S. Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial. Neurology 2003 60 (2) 315-321
8. Wang S J., Silberstein S D., Young W B. Droperidol treatment of status migrainosus and refractory migraine. Headache 1997 37 (6) 377-382
9. Weaver C S., Jones J B., Chisholm C D. et al. Droperidol vs prochlorperazine for the treatment of acute headache. J Emerg Med 2004 26 (2) 145-150
10. Miner J R., Fish S J., Smith S W., Biros M H. Droperidol vs. prochlorperazine for benign headaches in the emergency department. Acad Emerg Med 2001 8 (9) 873-879
11. Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989 261 (8) 1174-1176
12. Coppola M, Yealy D M., Leibold R A. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995 26 (5) 541-546
13. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med 1996 14 (3) 262-264
14. Tanen D A., Miller S, French T, Riffenburgh R H. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 2003 41 (6) 847-853
15. Seim M B., March J A., Dunn K A. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med 1998 5 (6) 573-576
16. Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 2009 9 (3) 369-379
17. Bigal M E., Bordini C A., Speciali J G. Intravenous chlorpromazine in the acute treatment of episodic tension-type headache: a randomized, placebo controlled, double-blind study. Arq Neuropsiquiatr 2002 60 (3-A, 3-A) 537-541
18. Bell R, Montoya D, Shuaib A, Lee M A. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990 19 (10) 1079-1082
19. Kelly A M., Walcynski T, Gunn B. The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis. Headache 2009 49 (9) 1324-1332
20. Colman I, Brown M D., Innes G D., Grafstein E, Roberts T E., Rowe B H. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 2004 329 (7479) 1369-1373
21. Ellis G L., Delaney J, DeHart D A., Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med 1993 22 (2) 191-195
22. Tek D S., McClellan D S., Olshaker J S., Allen C L., Arthur D C. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990 19 (10) 1083-1087
23. Rapoport A M., Silberstein S D. Emergency treatment of headache. Neurology 1992 42 (3, Suppl 2) 43-44
24. Perry C M., Markham A. Sumatriptan. An updated review of its use in migraine. Drugs 1998 55 (6) 889-922
25. Lobo B L., Cooke S C., Landy S H. Symptomatic pharmacotherapy of migraine. Clin Ther 1999 21 (7) 1118-1130
26. Salonen R, Scott A. Triptans: do they differ? Curr Pain Headache Rep 2002 6 (2) 133-139
27. Mett A, Tfelt-Hansen P. Acute migraine therapy: recent evidence from randomized comparative trials. Curr Opin Neurol 2008 21 (3) 331-337
28. Tfelt-Hansen P, De Vries P, Saxena P R. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000 60 (6) 1259-1287
29. Rapoport A M., Tepper S J., Bigal M E., Sheftell F D. The triptan formulations: how to match patients and products. CNS Drugs 2003 17 (6) 431-447
30. Silberstein S D., McCrory D C. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache 2003 43 (2) 144-166
31. Raskin N H. Treatment of status migrainosus: the American experience. Headache 1990 30 (Suppl 2) 550-553
32. Ford R G., Ford K T. Continuous intravenous dihydroergotamine in the treatment of intractable headache. Headache 1997 37 (3) 129-136
33. Swidan S Z., Lake A E. III, Saper J R. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Headache Rep 2005 9 (1) 65-70
34. Saadah H A. Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache 1994 34 (6) 366-370
35. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache 2005 45 (7) 850-861
36. Krymchantowski A V. The use of combination therapies in the acute management of migraine. Neuropsychiatr Dis Treat 2006 2 (3) 293-297
37. Brandes J L., Kudrow D, Stark S R. et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007 297 (13) 1443-1454
38. Baden E Y., Hunter C J. Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: a randomized, double-blind, placebo-controlled clinical trial. CJEM 2006 8 (6) 393-400
39. Rowe B H., Colman I, Edmonds M L., Blitz S, Walker A, Wiens S. Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache 2008 48 (3) 333-340
40. Fiesseler F W., Shih R, Szucs P et al. Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial. J Emerg Med 2009 October 19 (Epub ahead of print)
41. Singh A, Alter H J., Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med 2008 15 (12) 1223-1233
42. Colman I, Friedman B W., Brown M D. et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 2008 336 (7657) 1359-1361
43. Gallagher R M. Emergency treatment of intractable migraine. Headache 1986 26 (2) 74-75
44. Rozen T D. Acute therapy for migraine headaches. Semin Neurol 2006 26 (2) 181-187
45. Edwards K R., Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001 41 (10) 976-980
46. Mathew N T., Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000 40 (9) 720-723
47. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia 2005 25 (3) 199-204
48. Corbo J, Esses D, Bijur P E., Iannaccone R, Gallagher E J. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 2001 38 (6) 621-627
49. Bigal M E., Bordini C A., Tepper S J., Speciali J G. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 2002 22 (5) 345-353
50. Mauskop A, Altura B T., Cracco R Q., Altura B M. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996 36 (3) 154-160
51. Friedman B W., Kapoor A, Friedman M S., Hochberg M L., Rowe B H. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med 2008 52 (6) 705-713
52. Ho T W., Mannix L K., Fan X et al, MK-0974 Protocol 004 study group. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008 70 (16) 1304-1312
53. Ho T W., Ferrari M D., Dodick D W. et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 2008 372 (9656) 2115-2123
54. Connor K M., Shapiro R E., Diener H C. et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 2009 73 (12) 970-977
55. Petersen K A., Birk S, Lassen L H. et al. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 2005 25 (2) 139-147
56. Olesen J, Diener H C., Husstedt I W. et al, BIBN 4096 BS Clinical Proof of Concept Study Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004 350 (11) 1104-1110
57. Villalon C M., Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 2009 124 (3) 309-323
58. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004 24 (Suppl 1) 1-160
59. Capobianco D J., Dodick D W. Diagnosis and treatment of cluster headache. Semin Neurol 2006 26 (2) 242-259
60. The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991 325 (5) 322-326
61. Dodick D W., Capobianco D J. Treatment and management of cluster headache. Curr Pain Headache Rep 2001 5 (1) 83-91
62. Kudrow L. Cluster Headache. Mechanisms and Management. Oxford Oxford University Press 1980
63. Mathew N T. Cluster headache. Semin Neurol 1997 17 (4) 313-323
64. Loder E. Migraine in pregnancy. Semin Neurol 2007 27 (5) 425-433
65. Menon R, Bushnell C D. Headache and pregnancy. Neurologist 2008 14 (2) 108-119
66. Briggs G G., Freeman R K., Yaffe S J. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia Lippincott Williams & Wilkins 2008
67. Marcus D A. Managing headache during pregnancy and lactation. Expert Rev Neurother 2008 8 (3) 385-395
68. Olesen C, Steffensen F H., Sorensen H T., Nielsen G L., Olsen J. Pregnancy outcome following prescription for sumatriptan. Headache 2000 40 (1) 20-24
69. Friedman B W., Hochberg M L., Esses D et al. Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes. Ann Emerg Med 2008 52 (6) 696-704
70. Gupta M X., Silberstein S D., Young W B., Hopkins M, Lopez B L., Samsa G P. Less is not more: underutilization of headache medications in a university hospital emergency department. Headache 2007 47 (8) 1125-1133
71. Peterlin B L., Rapoport A M. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol 2007 3 (6) 899-911